Catalyst News and Research

RSS

Expert advice for the corporate titans taking on health care

An announcement Tuesday by three of the nation's corporate titans — Amazon, Berkshire Hathaway and JPMorgan Chase & Co. — that they are joining forces to address the high costs of employee health care has stirred the health policy pot. It immediately sent shock waves through the health sector of the stock market and reinvigorated talk about health care technology, value and quality.

31 Jan 2018

Long-term intake of sunflower, fish oils affects the liver

An international group of scientists led by the University of Granada (UGR) has demonstrated that the long-term intake of sunflower or fish oils damages the liver and can cause a series of alterations in it, giving rise to non-alcoholic steatohepatitis.

31 Jan 2018

Biotechnology startup receives FDA clearance for synthetic bone graft substitute

A biotechnology startup enabled by UC Davis, Molecular Matrix Inc., has received Food and Drug Administration clearance for a carbohydrate-based polymer that can help injured bones heal and regrow.

27 Jan 2018

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000.000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).

27 Jan 2018

BIST researchers develop new retinal prosthesis to address visual degeneration

A healthy retina contains photoreceptor cells that convert light changes into nerve impulses, which are then carried along the optic nerve to the brain, where they are decoded into images. Diseases such as retinitis pigmentosa cause the photoreceptor cells to stop functioning, while the rest of the eye remains healthy.

24 Jan 2018

New initiative seeks to transform the way people live with dementia

Challenge Dementia, supported by Nesta, launches today as the first national search for next generation products, technologies and services that could transform the way people live with dementia helping them to live enjoyable and fulfilling lives for as long as possible.

19 Jan 2018

Unique reusable treatment effectively destroys cancer cells

Cancer cells can be destroyed more effectively and selectively with a unique new reusable treatment, activated with a substance found in stinging nettles and ants - thanks to new research by the University of Warwick.

10 Jan 2018

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.

9 Jan 2018

Long-term night shift work among women may increase risk of cancers

Night shift work was associated with women having an increased risk of breast, skin, and gastrointestinal cancer, according to a meta-analysis.

8 Jan 2018

Mutational patterns could identify breast cancer patients most likely to respond to platinum-based chemotherapy

The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.

19 Dec 2017

An overlooked epidemic: Older Americans taking too many unneeded drugs

Consider it America’s other prescription drug epidemic. For decades, experts have warned that older Americans are taking too many unnecessary drugs, often prescribed by multiple doctors, for dubious or unknown reasons.

12 Dec 2017

Oral bacteria that lead to periodontal disease linked to higher risk of esophageal cancer

An analysis of bacteria present in the mouth showed that some types of bacteria that lead to periodontal disease were associated with higher risk of esophageal cancer.

1 Dec 2017

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.

30 Nov 2017

ACS program effective in improving colorectal cancer screening rates

A new study suggests that an American Cancer Society program has been effective in promoting improvements in colorectal cancer screening rates in federally qualified health centers.

30 Nov 2017

Wonder Woman of preconception care

Health care might have found its Wonder Woman. She can identify health risks in young African-American women and help them successfully resolve those risks.

30 Nov 2017

Urban American-Indian, Alaskan Native community more likely to have lower cancer survival rates

Compared with the non-Hispanic white population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer.

29 Nov 2017

TSRI chemists invent new method that simplifies late-stage modification of drug molecules

Chemists at The Scripps Research Institute have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

27 Nov 2017

Childhood cancer survivors more likely to have high blood pressure as adults

People who survived childhood cancer were more than twice as likely as the general population to have high blood pressure (hypertension) as adults.

22 Nov 2017

Thyroid cancer survivors have higher risk for aging-related diseases

Risk for aging-related diseases such as heart disease and diabetes was significantly higher among thyroid cancer survivors in Utah than it was among age-matched, cancer-free individuals, with those diagnosed before age 40 having the highest risk for some of the diseases.

22 Nov 2017

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

17 Nov 2017

Catalyst News and Research

Expert advice for the corporate titans taking on health care

Long-term intake of sunflower, fish oils affects the liver

Biotechnology startup receives FDA clearance for synthetic bone graft substitute

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

BIST researchers develop new retinal prosthesis to address visual degeneration

New initiative seeks to transform the way people live with dementia

Unique reusable treatment effectively destroys cancer cells

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

Long-term night shift work among women may increase risk of cancers

Mutational patterns could identify breast cancer patients most likely to respond to platinum-based chemotherapy

An overlooked epidemic: Older Americans taking too many unneeded drugs

Oral bacteria that lead to periodontal disease linked to higher risk of esophageal cancer

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

ACS program effective in improving colorectal cancer screening rates

Wonder Woman of preconception care

Urban American-Indian, Alaskan Native community more likely to have lower cancer survival rates

TSRI chemists invent new method that simplifies late-stage modification of drug molecules

Childhood cancer survivors more likely to have high blood pressure as adults

Thyroid cancer survivors have higher risk for aging-related diseases

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News